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Abstract
BACKGROUND—Socioeconomic status (SES) plays an important role in colorectal cancer 
(CRC) mortality, although the independent and joint effects with nativity and neighborhood factors 
have yet to be evaluated.
METHODS—With nearly one-third of all US Hispanics residing in California, the authors 
obtained information from the California Cancer Registry to examine the associations between 
neighborhood SES and mortality in all 33,146 Hispanic individuals diagnosed with CRC from 
1988 through 2010, with a particular focus on associations among US-born and foreign-born 
Hispanics. Cox proportional hazards models were used to calculate hazard ratios (HRs) and 95% 
confidence intervals (95% CI) for overall and CRC-specific mortality.
RESULTS—Hispanics residing in lower SES neighborhoods demonstrated a higher rate of 
overall and CRC-specific mortality than those residing in high SES neighborhoods (SES quintile 
1[low] vs quintile 5 [high]: HR, 1.15 [95% CI, 1.05–1.26] and HR, 1.16 [95% CI, 1.03–1.30], 
respectively). Nativity modified the associations between SES and mortality (P for interaction, .02 
for overall and P for interaction, .01 for CRC-specific mortality) such that the SES associations 
were observed only among US-born (P for trend < .01 for overall and CRC-specific mortality) but 
not among foreign-born Hispanics.
CONCLUSIONS—Neighborhood SES demonstrates significant differential effects on overall 
and CRC-specific mortality between US-born and foreign-born Hispanics. Future efforts should 
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investigate the underlying contextual and individual-level factors that could account for these 
differential associations by nativity.
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INTRODUCTION
By the end of 2013, Hispanics were expected to represent the largest ethnic group in 
California, which has important implications for their health care needs and services. 
Currently, cancer is the leading cause of death among Hispanics in the United States. 
Colorectal cancer (CRC) was estimated in 2012 as the second and third leading cause of 
cancer deaths among US Hispanic men and women, respectively, after lung cancer for men 
and breast and lung cancer for women.1 Mortality after CRC may be attributed to the 
complex interplay between clinical, social, economic, behavioral, and biological factors. 
Socioeconomic status (SES) is a key factor affecting mortality because it influences 
underlying prognostic factors, access to health insurance, early detection, and treatment.1 
This is important for Hispanics, who experience a lower median income and a higher 
poverty rate than the overall US population.2 Furthermore, substantial SES differences are 
noted among Hispanics according to nativity. For example, foreign-born Hispanics have 
lower median household income and lower educational attainment than US-born Hispanics.2 
In addition, foreign-born Hispanics tend to live in Hispanic enclaves (neighborhoods with 
high percentages of Hispanics or Hispanic immigrants), which are generally neighborhoods 
of lower SES.3,4
Previous studies have for the most part observed an inverse association between SES and 
CRC mortality, with lower mortality rates observed among those of higher SES.5–11 This 
inverse association has been shown to persist with adjustment of stage of disease,12,13 an 
important clinical predictor of prognosis. To our knowledge, few studies to date have 
specifically included Hispanics7,10,11 and inconsistent associations have been reported. In a 
recent study of the California Cancer Registry (CCR), lower CRC mortality rates were 
observed with higher neighborhood SES among Hispanics, in contrast to higher mortality 
rates with higher SES noted for non-Hispanic whites and African Americans.7 This 
relationship between SES and CRC mortality remains to be clearly understood and 
differences by nativity, an important factor for health outcomes among Hispanics, has to our 
knowledge yet to be examined.
For the current study, we used the unique resource of the CCR enhanced with data regarding 
patient-level nativity and residential neighborhood factors including SES and degree of 
ethnic enclave status. Specifically, we conducted a large prospective analysis of 33,146 
Hispanics with CRC to examine the association between SES and mortality after a CRC 
diagnosis, with a particular focus on US-born and foreign-born Hispanics.
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MATERIALS AND METHODS
Study Population
We obtained CCR data on all patients diagnosed with primary invasive CRC (International 
Classification of Disease for Oncology-3rd Edition site codes C180–209, excluding 
histology codes 9050–9055, 9140, and 9590–9992) between January 1, 1988 and December 
31, 2010. For each patient, we obtained CCR information regarding age, sex, race/ethnicity, 
marital status, census block group of residence at the time of diagnosis, stage at diagnosis 
(summarized as localized, regional, metastasized, or unknown), treatment modalities within 
the first 12 months after diagnosis, vital status as of December 31, 2010, and underlying 
cause of death. The North American Association of Central Cancer Registries Hispanic 
Identification Algorithm,14 which is based on surname, maiden names, and/or birthplace, 
was used to improve the classification of Hispanic ethnicity.15,16 All Hispanics with invasive 
CRC regardless of race were included. Classification of nativity (US-born or foreign-born) 
was described in detail previously.17,18 Briefly, data regarding nativity were available in the 
CCR for 77% of the eligible cases for this study (62% from hospital records and 15% from 
death certificates). We estimated nativity for 21% of patients with unknown birthplace using 
a statistical imputation method that has been shown to have minimal bias.19 Based on each 
patient’s social security number (SSN), which indicates the state and year of issuance,20,21 
we classified patients who received their SSN before age 20 years as US-born and those who 
received their SSN at or after age 20 years as foreign-born. The cutpoint of 20 years was 
determined by comparison with self-reported nativity from interviews with 1127 Hispanic 
patients with cancer and maximization of the area under the resultant receiver operating 
characteristic curve.22,23 The selected cutpoint resulted in immigrant status classifications 
associated with 81% sensitivity and 80% specificity for detecting foreign-born status in 
Hispanics. The remaining 2% of patients were assigned by age nativity distribution of the 
overall sample (2%).20,21
We determined neighborhood SES by patients’ residential census block group using an 
index derived from principal components of 7 indicator variables of SES (education level; 
percentage unemployed and with a blue collar job; percentage at < 200% of the poverty line; 
and median household income, rent, and home value) using 2000 US Census data.24 We also 
classified patients according to neighborhood Hispanic enclave status, which was based on 
the 2000 US Census block-group level variables (percentage linguistically isolated, 
percentage linguistically isolated who speak Spanish, percentage speaking limited English, 
percentage speaking limited English who spoke Spanish, percentage of recent immigrants, 
percentage Hispanic, and percentage foreign-born) and derived using principal components 
analysis. Methodological details were described previously.17,18 Each patient with CRC was 
assigned into an SES or a Hispanic enclave quintile based on the distribution of 
neighborhood SES or Hispanic enclave, respectively, across all census block groups in 
California. After excluding 231 patients diagnosed at autopsy or by death certificate, the 
current study included 33,146 Hispanic individuals with invasive CRC. This project was 
approved by the Institutional Review Board of the Cancer Prevention Institute of California.
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Statistical Analysis
We used Cox proportional hazards regression to estimate hazard ratios (HRs) and associated 
95% confidence intervals (95% CI) to estimate associations with overall and CRC-specific 
mortality. For deceased patients, survival time was measured in days from the date of 
diagnosis to the date of death from any cause for all-cause mortality analyses or to the date 
of death from CRC for CRC-specific mortality analyses. Patients who died of other causes 
were censored at the time of death for analyses of CRC-specific death. Patients alive at the 
study end date (December 31, 2010) were censored at this time or at the date of last follow-
up (ie, last known contact). Approximately 93% of censored patients had a follow-up date 
within 1 year of the study end date.
We tested the proportional hazards assumption by statistically testing the correlation 
between weighted Schoenfeld residuals and logarithmically transformed survival time. No 
violations of the assumption were observed. Multivariate Cox regression models included 
variables significant at P < .05 in unadjusted models (year of diagnosis, nativity, age at 
diagnosis, sex, marital status, neighborhood SES, Hispanic enclave, tumor size, tumor grade, 
and first course of treatment). Given that proportional hazards varied by stage at diagnosis 
(localized, regional, metastasized, and unknown), it was included as a stratifying variable in 
all Cox regression models, allowing the baseline hazard to vary across stage. All models 
were adjusted for clustering effect by block group. To examine whether the association for 
Hispanic enclave was independent from SES, Hispanic enclave was included in regression 
models with SES. Effect modification of the associations between neighborhood SES and 
mortality risk by nativity and stage at diagnosis were assessed by including an interaction 
term in the multivariable models and were considered present if the interaction terms were 
significant at P < .05. Stratification analyses were also conducted to examine the patterns of 
associations by nativity and stage at diagnosis. All statistical tests were performed using 
SAS statistical software (version 9.3; SAS Institute Inc, Cary, NC). All P values reported 
were 2-sided, and those that were < .05 were considered to be statistically significant.
RESULTS
In this California cohort of 33,146 Hispanic patients with CRC, the mean age of the patients 
at the time of diagnosis was 63.6 (standard deviation [SD], 14.6) years (63.4 [SD, 13.9] 
years and 63.7 [SD, 15.3] years for US-born and foreign-born Hispanics, respectively). 
Approximately 52% of the patients were born in the United States. A total of 54% of the 
patients were male and 57% were married. Approximately 35%, 39%, and 21% of US-born 
Hispanic patients with CRC and a similar 34%, 39%, and 22% of foreign-born Hispanic 
patients were diagnosed with localized, regional, and metastasized cancers, respectively (P 
value for difference, .21). Compared with US-born Hispanics, foreign-born Hispanic 
patients were more likely to be diagnosed after 2002 and to live in lower SES and higher 
Hispanic enclave neighborhoods (P < .05). Approximately 26% and 25% of the US-born 
Hispanics lived in the lowest SES and highest Hispanic enclave neighborhoods, respectively, 
compared with 35% and 39%, respectively, of the foreign-born Hispanic patients (Table 1).
With a mean follow-up of 4.8 years (± 5.0 years), the median overall survival was 5.9 years 
(95% CI, 5.7 years-6.0 years). Table 2 shows that compared with US-born Hispanic patients 
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with CRC, foreign-born Hispanics demonstrated significantly lower overall mortality (HR, 
0.89; 95% CI, 0.85–0.92) and CRC-specific mortality (HR, 0.89; 95% CI, 0.85–0.94) after 
adjusting for neighborhood SES, Hispanic enclave, and other factors. Hispanics residing in 
lower SES neighborhoods experienced a higher rate of overall and CRC-specific mortality 
than those residing in high SES neighborhoods (P value for trend, .003). Specifically, 
compared with patients living in the highest SES neighborhoods, patients in the lowest SES 
neighborhoods had a 15% (95% CI, 1.06–1.26) increased rate of all-cause mortality and a 
16% (95% CI, 1.03–1.30) increased rate of CRC-specific mortality. Although these findings 
suggested that Hispanics residing in neighborhoods with higher levels of Hispanic enclave 
were at an increased rate of mortality, this association was completely attenuated after 
adjusting for neighborhood SES (Table 2).
We observed heterogeneous associations between neighborhood SES and mortality rates by 
stage of disease at the time of diagnosis among Hispanic patients with CRC (P value for 
interaction, .046 and .03, respectively, for overall and CRC-specific mortality) (Table 3). 
Patients living in the lowest SES neighborhoods who were diagnosed with localized/regional 
CRC had an 18% and 25% greater risk of death from all causes and CRC, respectively, 
compared with patients in the highest SES neighborhoods (P value for trend, < .005), 
whereas no significant elevated risk was observed for patients diagnosed with metastasized 
CRC. In addition, heterogeneous associations between SES and mortality were observed by 
nativity (P value for interaction, .02 and .01, respectively, for overall and CRC-specific 
mortality) (Table 4). Among US-born Hispanics, there were highly significant inverse 
associations noted between neighborhood SES and all-cause and CRC-specific mortality (P 
value for trend < .001) such that US-born Hispanics living in the lowest SES neighborhoods 
had a 1.2-fold increased risk of overall and CRC-specific mortality compared with those 
living in the highest SES neighborhoods (P value for trend, < .001). Conversely, among 
foreign-born His-panics, no significant trends were observed between neighborhood SES 
and overall and CRC-specific mortality. We conducted sensitivity analyses by excluding the 
765 Hispanic patients (379 who were US-born [1.1%] and 386 who were foreign-born 
[1.2%]) with missing or invalid SSNs and found that it did not affect our overall results.
DISCUSSION
In this large prospective study of 33,146 Hispanic patients with CRC from California, 
foreign-born Hispanics experienced a significantly lower rate of death from CRC and all 
causes compared with US-born Hispanics. Hispanics living in low SES neighborhoods had 
an increased risk of overall and CRC-specific mortality compared with those from high SES 
neighborhoods. Importantly, this inverse association between neighborhood SES and 
mortality risk for patients with CRC was considerably more pronounced in patients 
diagnosed with localized/regional CRC than those with metastasized CRC, as well as in US-
born Hispanics compared with in foreign-born Hispanics.
The current study findings of inverse associations between SES and risk of CRC-specific 
and overall mortality among Hispanics are consistent with other studies that have examined 
this association among patients with CRC of all racial/ethnic groups combined in the United 
States.5,9,10,25 We previously observed an association between higher neighborhood SES 
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and lower CRC incidence and mortality rates among the Hispanic population of California 
from 1988 to 2002.7 With our more precise survival analysis, modeling time to death and 
adjustment of key explanatory factors, we have been able to clarify that the previously 
observed association between higher SES and a lower CRC mortality rate was entirely 
reflective of the SES relationship with CRC incidence, given our current finding of poorer 
survival associated with lower SES.
It is interesting to note that our finding of improved survival among foreign-born Hispanic 
patients with CRC supports previous studies that have described a Hispanic immigrant 
health advantage with survival after diagnoses of breast, prostate, and lung cancer.18,26,27 
This health advantage among Hispanic immigrants indicates the tendency for foreign-born 
Hispanics to have a better health advantage despite their unfavorable SES compared with 
US-born Hispanics.28–30 There are several possible explanations for this observation. First, 
the improved survival in immigrants could be a result of the underascertainment of deaths or 
loss to follow-up. In the data from the current study, US-born Hispanics were found to have 
a shorter time interval between the date of last follow-up and the study end date compared 
with foreign-born Hispanics (average, 0.33 years in foreign-born Hispanics vs 0.81 years in 
US-born Hispanics), which would suggest that foreign-born patients may return to their 
native countries after a cancer diagnosis and die (a phenomena referred as “reverse 
migration”). However, we observed a similar association in sensitivity analyses when 1) 
excluding all patients who were censored and lost to follow-up (> 2 years between last 
follow-up date and the study end date), which included 250 US-born and 735 foreign-born 
Hispanics; or 2) changing the vital status of those patients with advanced stage disease to 
“deceased” among those lost to follow-up. This suggests the magnitude of emigration would 
not likely bias our observations. Second, selective migration of “healthy immigrants” may 
also play a role in the lower overall mortality observed in immigrants.31–33 However, prior 
studies have shown that although the effect of “reverse migration” and the “healthy 
immigrants” may exist to some extent, they could only partially explain the Hispanic 
paradox.28,29,32 Alternatively, this paradox could be due to a true health advantage among 
the Hispanic immigrants.
To our knowledge, the current study is the first to report that the magnitude of the 
neighborhood SES mortality disparity was more striking in US-born compared with foreign-
born Hispanics. SES is an important prognostic determinant for most common cancers, 
including breast and prostate cancer.25,34 Although to our knowledge there is no existing 
evidence to support such a disparity by nativity among Hispanic patients with CRC, it is 
likely that inequality in treatment may partially explain the substantial impact of 
neighborhood SES on CRC mortality. In the current study, we observed, among patients who 
were diagnosed with localized or regional CRC, evidence of an interaction between 
neighborhood SES and nativity on CRC-specific mortality (P value for interaction, .048) that 
was attenuated after adjusting for the first course of treatment, including surgery, 
chemotherapy, and radiotherapy (P value for interaction, .071). However, in our main 
analysis as well as stratified analyses by stage of disease at diagnosis and by nativity, the 
SES gradient on CRC mortality remained after adjusting for multiple patient and clinical 
characteristics including treatment, which would suggest that differences in neighborhood 
SES associations between US-born and foreign-born Hispanics is unlikely fully explained 
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by stage of disease at diagnosis, patients’ demographic and clinical factors, and first course 
of treatment.
In addition to medical treatment, immigration-related factors may play an important role in 
the marked difference in SES associations observed between US-born and foreign-born 
Hispanics. Although foreign-born Hispanics are more likely to be of low SES with lower 
average levels of income and education, they also tend to have high levels of social cohesion 
and to retain cultural and behavioral norms, such as intact family structures and normative 
socialization, which provide support to residents against socioeconomic distress.36–38 These 
social and cultural supports can be advantageous with respect to cancer survival. In addition, 
foreign-born Hispanics have been reported to possess favorable health behaviors, lifestyles, 
and attitudes toward health care and the use of traditional medicines that may mediate a 
survival benefit.39–45 Conversely, US-born Hispanics have been found to be more 
assimilated to unfavorable US dietary, lifestyle, and health behaviors, such as physical 
inactivity, obesity, and smoking,46–48 that may negatively impact their health outcomes. We 
examined the age-adjusted prevalence estimates of selected potential prognostic factors for 
CRC, including obesity, vegetable or fruit intake, cigarette smoking, and alcohol 
consumption49–51 in Hispanics by nativity based on the 2009 California Health Interview 
Survey. We found that among US-born Hispanics, 32% were obese (with a body mass index 
of had ≥30), 57% ≥5 servings of vegetables or fruit daily, 32% were ever-smokers, and 42% 
reported binge drinking within the past year, whereas the corresponding figures in foreign-
born Hispanics were 29%, 45%, 29%, and 27%, respectively, for obesity, vegetable or fruit 
intake, smoking, and binge drinking. These and other “Westernized lifestyle” factors may 
lead to poor survival outcomes among acculturated US-born Hispanics. Furthermore, 
although we did not observe a difference in the age-adjusted prevalence of diabetes, an 
established prognostic factor for CRC,52 in the California Health Interview Survey, by 
Hispanic nativity, a higher prevalence of diabetes was observed in US-born compared with 
foreign-born Hispanics.53 Given that low SES is associated with an increased risk of 
diabetes,54 it is possible that the high prevalence of diabetes noted among US-born 
Hispanics living in low SES neighborhoods may lead to a higher mortality rate compared 
with foreign-born Hispanics residing in similar neighborhoods. Although to our knowledge 
the reasons underlying the modification effect of neighborhood SES on the association 
between nativity and cancer survival is unknown, our finding of a marked inverse association 
between neighborhood SES and mortality in US-born but not foreign-born Hispanic patients 
with CRC suggests that US-born Hispanics may experience more significant differences in 
terms of level of social support and adoption of the Westernized lifestyles and health 
behaviors across the neighborhood SES gradient compared with foreign-born Hispanics 
residing in similar neighborhoods.
The current study has distinct strengths of a population-based design and the power to detect 
variations in CRC mortality across neighborhood SES and nativity among Hispanics. Our 
comprehensive measure of SES includes several domains such as education, income, and 
employment, which capture various elements of the socioeconomic environment. In 
addition, our classification of Hispanic ethnicity was based on a validated method developed 
to enhance classification based on surnames, given names, and birthplace.14 Our 
measurement of nativity, which relied on an imputation method for the 23% of patients with 
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CRC for whom there was missing registry data regarding birthplace, is also highly accurate 
in comparison with recorded registry birthplace23 or death certificates.22 There are 
limitations to the current study because we were unable to adjust for some clinical 
characteristics and lifestyle/demographic factors such as treatment beyond the first course of 
therapy, comorbidities, health behaviors, and individual-level SES. It is also worth noting 
that despite the significant difference in the modification effect of neighborhood SES on 
mortality by nativity, the associations between neighborhood SES and Hispanic enclave on 
overall and CRC-specific mortality in all Hispanic patients was not significant in the current 
study.
Neighborhood SES demonstrates differential effects on overall and CRC-specific mortality 
between US-born and foreign-born Hispanics. Further migrant studies are clearly needed to 
identify the underlying factors that drive survival advantages for CRC among this growing 
population of Hispanics in the United States.
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TABLE 1
Demographic and Clinical Characteristics for Hispanic Patients Diagnosed With Invasive CRC by Nativity: 
California, 1988 to 2010
Characteristic
All Cases
(n = 33,146)
US-Born
(n = 17,160)
Foreign-Born
(n = 15,986)
Sociodemographic characteristics No. (%) No. (%) No. (%)
Y of diagnosis
 1988–1992 4734 (14.3%) 2619 (15.3%) 2115 (13.2%)
 1993–1997 5506 (16.6%) 3049 (17.8%) 2457 (15.4%)
 1998–2002 7381 (22.3%) 3885 (22.6%) 3496 (21.9%)
 2003–2007 9250 (27.9%) 4545 (26.5%) 4705 (29.4%)
 2008–2010 6275 (18.9%) 3062 (17.8%) 3213 (20.1%)
Age at diagnosis, y
 <50 5711 (17.2%) 2751 (16.0%) 2960 (18.5%)
 50–59 6808 (20.5%) 3543 (20.6%) 3265 (20.4%)
 60–69 8409 (25.4%) 4709 (27.4%) 3700 (23.1%)
 70–79 7561 (22.8%) 4135 (24.1%) 3426 (21.4%)
 ≥80 4657 (14.0%) 2022 (11.8%) 2635 (16.5%)
Sex
 Male 17,876 (53.9%) 9567 (55.8%) 8309 (52.0%)
 Female 15,270 (46.1%) 7593 (44.2%) 7677 (48.0%)
Marital status at diagnosis
 Married 18,925 (57.1%) 9752 (56.8%) 9173 (57.4%)
 Never married 4746 (14.3%) 2423 (14.1%) 2323 (14.5%)
 Previously married 8220 (24.8%) 4394 (25.6%) 3826 (23.9%)
 Unknown 1255 (3.8%) 591 (3.4%) 664 (4.2%)
Neighborhood SES
 Quintile 1 (low) 10,016 (30.2%) 4471 (26.1%) 5545 (34.7%)
 Quintile 2 8228 (24.8%) 4241 (24.7%) 3987 (24.9%)
 Quintile 3 6525 (19.7%) 3644 (21.2%) 2881 (18.0%)
 Quintile 4 5036 (15.2%) 2890 (16.8%) 2146 (13.4%)
 Quintile 5 (high) 3341 (10.1%) 1914 (11.2%) 1427 (8.9%)
Hispanic enclave
 Quintile 1 (low) 2195 (6.6%) 1519 (8.9%) 676 (4.2%)
 Quintile 2 3585 (10.8%) 2264 (13.2%) 1321 (8.3%)
 Quintile 3 4967 (15.0%) 2938 (17.1%) 2029 (12.7%)
 Quintile 4 7699 (23.2%) 4033 (23.5%) 3666 (22.9%)
 Quintile 5 (high) 10,516 (31.7%) 4254 (24.8%) 6262 (39.2%)
 Unknown/missing 4184 (12.6%) 2152 (12.5%) 2032 (12.7%)
Clinical characteristics
 Tumor stage
 Localized 11,392 (34.4%) 6021 (35.1%) 5371 (33.6%)
 Regional 13,022 (39.3%) 6762 (39.4%) 6260 (39.2%)
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Characteristic
All Cases
(n = 33,146)
US-Born
(n = 17,160)
Foreign-Born
(n = 15,986)
 Metastasized 7106 (21.4%) 3670 (21.4%) 3436 (21.5%)
 Unknown 1626 (4.9%) 707 (4.1%) 919 (5.7%)
Tumor grade
 Well differentiated 3151 (9.5%) 1640 (9.6%) 1511 (9.5%)
 Moderately differentiated 19,480 (58.8%) 10,268 (59.8%) 9212 (57.6%)
 Poorly/undifferentiated 5668 (17.1%) 2890 (16.8%) 2778 (17.4%)
 Unknown 4847 (14.6%) 2362 (13.8%) 2485 (15.5%)
Tumor size, cm
 0–2.00 2840 (8.6%) 1569 (9.1%) 1271 (8.0%)
 2.01–5.00 12,428 (37.5%) 6655 (38.8%) 5773 (36.1%)
 >5.00 9001 (27.2%) 4514 (26.3%) 4487 (28.1%)
 Microinvasion 48 (0.1%) 25 (0.1%) 23 (0.1%)
 Unknown/missing 8829 (26.6%) 4397 (25.6%) 4432 (27.7%)
Surgery
 No 4497 (13.6%) 2118 (12.3%) 2379 (14.9%)
 Yes 28,579 (86.2%) 15,016 (87.5%) 13,563 (84.8%)
 Unknown 70 (0.2%) 26 (0.2%) 44 (0.3%)
Chemotherapy
 No 19,968 (60.2%) 10,322 (60.2%) 9646 (60.3%)
 Yes 12,066 (36.4%) 6259 (36.5%) 5807 (36.3%)
 Unknown 1112 (3.4%) 579 (3.4%) 533 (3.3%)
Radiotherapy
 No 28,220 (85.1%) 14,627 (85.2%) 13,593 (85.0%)
 Yes 4884 (14.7%) 2519 (14.7%) 2365 (14.8%)
 Unknown 42 (0.1%) 14 (0.1%) 28 (0.2%)
Abbreviations: CRC, colorectal cancer; SES, socioeconomic status.
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 (0
.94
–1
.16
)
14
47
1.
18
 (1
.05
–1
.32
)
11
91
1.
02
 (0
.89
–1
.17
)
 
Qu
int
ile
 1 
(lo
w
)
26
09
1.
21
 (1
.11
–1
.33
)
27
68
1.
12
 (1
.02
–1
.24
)
15
96
1.
20
 (1
.07
–1
.34
)
16
62
1.
06
 (0
.93
–1
.21
)
 
P 
fo
r t
re
nd
<
.0
00
1
 
 
.
12
44
<
.0
00
1
 
 
.
98
51
A
bb
re
v
ia
tio
ns
: 9
5%
 C
I, 
95
%
 co
nf
id
en
ce
 in
te
rv
al
; C
RC
, c
ol
or
ec
ta
l c
an
ce
r; 
H
R,
 h
az
ar
d 
ra
tio
; S
ES
, s
oc
io
ec
on
om
ic
 st
at
us
.
a C
ox
 re
gr
es
sio
n 
m
od
el
 w
as
 a
dju
ste
d f
or 
ye
ar 
of 
dia
gn
osi
s, a
ge
 at
 di
ag
no
sis
, se
x
, 
tu
m
or
 g
ra
de
, t
um
or
 si
ze
, a
nd
 fi
rs
t c
ou
rs
e 
of
 tr
ea
tm
en
t (
su
rge
ry
,
 
ch
em
ot
he
ra
py
,
 
an
d 
ra
di
ot
he
ra
py
); 
clu
ste
rin
g e
ffe
ct
 b
y 
bl
oc
k 
gr
ou
p,
 st
ra
tif
ie
d 
by
 st
ag
e 
at
 d
ia
gn
os
is.
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